Efficacy of Oral Ivabradine in Patients Presenting With NSTEMI

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

100

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions

NSTEMI

Interventions

DRUG

Ivabradine

Ivabradine (5mg twice daily)

DRUG

Conventional Treatment

All Listed Sponsors

collaborator

National Heart Institute, Egypt

OTHER_GOV

lead

Cairo University

OTHER

NCT04285736 - Efficacy of Oral Ivabradine in Patients Presenting With NSTEMI | Biotech Hunter | Biotech Hunter